Mitochondrial Diseases – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Mitochondrial Diseases – Drugs In Development, 2024 report and make more profitable business decisions.
Mitochondrial diseases are a group of genetic conditions that affect how mitochondria function in your body. Mitochondria are the organelles that produce energy for the cell and are found in every cell of the human body except red blood cells. They convert the energy of food molecules into the ATP that powers most cell functions. Mitochondrial diseases can affect almost any part of your body, including the brain, nerves, muscles, kidneys, heart, liver, eyes, ears and pancreas. Mitochondrial diseases can emerge at any age and are enormously diverse in their clinical and molecular features. Some of the most common types of mitochondrial diseases are MELAS syndrome, LHON, Leigh syndrome, KSS, and MERRF. Mitochondrial diseases are diagnosed by a combination of clinical symptoms, biochemical tests, genetic tests and muscle biopsies. There are no cures for mitochondrial diseases, but treatment can help manage the symptoms and prevent complications.
The Mitochondrial Diseases drugs in development market research report provide comprehensive information on the therapeutics under development for Mitochondrial Diseases, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Mitochondrial Diseases and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Mitochondrial Diseases | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 33 molecules, with 31 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Mitochondrial Diseases therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Mitochondrial Diseases pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Mitochondrial Diseases treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Abliva ABAcahealth Pharma and Biotech Co Ltd
Astellas Pharma Inc
Clarus Therapeutics Holdings Inc
Curome Bioscience Co Ltd
CyteGen Corp
Demuris Ltd
Generian Pharmaceuticals Inc
Genflow Biosciences Srl
Khondrion BV
Kyowa Kirin Co Ltd
Mission Therapeutics Ltd
Mitobridge Inc
NysnoBio LLC
OMEICOS Therapeutics GmbH
Pretzel Therapeutics Inc
Primera Therapeutics Inc
PTC Therapeutics Inc
RiboNova Inc
Sentcell Ltd
Standigm Inc
Takaha Pharma Co Ltd
Tohoku University
Triplex Therapeutics Inc
University of Strasbourg
Yungjin Pharm Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Mitochondrial Diseases reports